dabigatran
Dabigatran is a pharmaceutical compound that functions as an active metabolite of the prodrug dabigatran etexilate. It is used in the manufacturing of anticoagulant medications for the prevention of stroke and systemic embolism.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 211914-51-1
Dabigatran ethyl ester
Pharmaceutical intermediate for dabigatran
Ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride
Pharmaceutical intermediate for anticoagulant
Étexilate de Dabigatran
active pharmaceutical ingredient
Asciminib hydrochloride
Active pharmaceutical ingredient
Calcitonin human
active pharmaceutical ingredient
(3ss)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol-d4; CB 7598-d4;
Active pharmaceutical ingredient
Dabigatran impurity P
Dabigatran impurity reference standard
Ethyl 3-[[[2-[[(4-cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionate
Pharmaceutical intermediate for dabigatran
3-[[2-[(4-carbamimidoylanilino)methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoic acid
YBSJFWOBGCMAKL-UHFFFAOYSA-N
CN1C2=C(C=C(C=C2)C(=O)N(CCC(=O)O)C3=CC=CC=N3)N=C1CNC4=CC=C(C=C4)C(=N)N